Development of cardioplegic solution without potassium: experimental study in rat [PDF]
INTRODUCTION: Myocardial preservation during open heart surgeries and harvesting for transplant are of great importance. The heart at the end of procedure has to resume its functions as soon as possible.
Karla Reichert +8 more
doaj +3 more sources
Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization. [PDF]
Nanocarriers for oxygen delivery have been the focus of extensive research to ameliorate the therapeutic effects of current anti-cancer treatments and in the organ transplant field.
Tannous M +6 more
europepmc +4 more sources
Single-centre, single-blind, randomized, active-controlled phase-3 non-inferiority study to investigate the safety and efficacy of the cardioplegic solution Cardioplexol™ [PDF]
ObjectivesEffective and reliable cardioplegic cardiac arrest is crucial for maximizing myocardial protection and preserving postoperative contractile function. Aim of this study was to demonstrate, in line with an ongoing European registration procedure,
Hendrik T. Tevaearai Stahel +12 more
doaj +4 more sources
A Cardioplegic Solution with an Understanding of a Cardiochannelopathy [PDF]
Cardiac surgeries have been improved by accompanying developing cardioplegia solutions. However, the cardioplegia application presents an ongoing challenge with a view of a sufficiently restored cardiac function.
Min Jeong Ji, Jeong Hee Hong
doaj +2 more sources
Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass. [PDF]
Backgrounds: On the basis of Custodiol preservation and cardioplegic solution a novel cardioplegic solution was developed to improve the postischemic cardiac and endothelial function.
Veres G +4 more
europepmc +4 more sources
Comparison of Clinical Outcomes of Two Different Cardioplegic Solutions in Patients Undergoing Coronary Artery Bypass Graft Surgery; A randomize clinical trial [PDF]
Background: Usually, manual cardioplegic solutions with low magnesium and lidocaine, and corporate solutions with high magnesium and procaine, are the only common solutions used to induce cardiac arrest during coronary artery bypass graft (CABG) surgery.
Alireza Hosseini +4 more
doaj +2 more sources
Effect of single-dose crystalloid cardioplegic agent compared to bloody cardioplegic agent in cardiac surgery in children with Tetralogy of Fallot [PDF]
BACKGROUND: Cardioplegia is one of the main post-operative cardiac protective factors widely used in recent decades in the form of crystalloid (St. Thomas) and bloody solutions [del Nido (DN)].
Hamid Bigdelian, Alireza Hosseini
doaj +3 more sources
Comparable renal effects of histidine-tryptophan-ketoglutarate and DelNido cardioplegia in a porcine model of cardiac arrest [PDF]
Acute kidney injury (AKI) is a serious complication following on-pump cardiac surgery. Choosing the cardioplegic solution with the most appropriate myocardial protection and lowest grade of AKI could improve patient outcome.
Maja-Theresa Dieterlen +8 more
doaj +2 more sources
The Potential Role of MicroRNAs as Cardioprotective Agents During Cardioplegia: A Preliminary Qualitative Systematic Review. [PDF]
ABSTRACT Background and Aims Recent advancements in gene expression studies have shed light on the role of non‐coding RNAs in negatively regulating mRNA and inhibiting mRNA translation. Given the significant impact of miRNAs on cardiovascular function, our review aims to comprehensively explore their contribution to mitigating heart injury and their ...
Baniani M +3 more
europepmc +2 more sources
Solução cardioplégica polarizante: estado da arte Polarizing cardioplegic solution: state of the art [PDF]
A exegese do termo cardioplegia remete aos significados de "lesão, golpe, ataque ou ferimento", bem diferente, portanto, do sentido em que o termo é empregado na maior parte dos centros de cirurgia cardíaca do Brasil e do mundo, ou seja, como ...
Marcos Aurélio Barboza de Oliveira +3 more
doaj +2 more sources

